Lexicon Pharmaceuticals Presents Clinical Data at 80th American Diabetes Association Scientific Sessions

by NASDAQ Market News June 13, 2020

NASDAQ Market News
Click here to email author

Esperion Announces Pooled Analysis from Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL™ (Bempedoic Acid) Tablets Presented at the American Diabetes Association 80th Scientific Sessions

Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice

Ads